Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors

M. C. Shuhart, D. Myerson, C. L. Spurgeon, C. A. Bevan, M. H. Sayers, G. B. McDonald

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In March 1992, 12 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center received blood components from donors who were anti-HCV-nonreactive by first generation ELISA but whose serum later tested anti-HCV-reactive to a second generation ELISA. All these blood components were further tested for anti-HCV using a second-generation RIBA and for HCV RNA by polymerase chain reaction. Recipient sera were tested for HCV RNA prior to and following blood component infusion. Blood components from four donors were positive for HCV RNA. All recipients of HCV RNA-positive blood components became viremic on the first day tested post-infusion. In addition, two recipients of HCV RNA-negative blood components tested HCV RNA-positive both pre- and post-infusion. Viremia persisted up to the time of death or day 100 in five of the six patients who were HCV RNA-positive post-transplant. No HCV RNA-positive recipient developed symptomatic acute hepatitis, and only two had aminotransferase elevations consistent with chronic hepatitis. We conclude that HCV RNA-positivity in blood components accurately predicts transmission of virus. Infection with HCV did not adversely affect short-term patient outcome following bone marrow transplantation.

Original languageEnglish (US)
Pages (from-to)601-606
Number of pages6
JournalBone Marrow Transplantation
Volume17
Issue number4
StatePublished - Apr 1996

Fingerprint

Virus Diseases
Blood Donors
Hepacivirus
Bone Marrow
Transplants
RNA
Enzyme-Linked Immunosorbent Assay
Viremia
DNA-Directed RNA Polymerases
Chronic Hepatitis
Transaminases
Serum
Bone Marrow Transplantation
Hepatitis
Tissue Donors

Keywords

  • Blood transfusion
  • Bone marrow transplantation
  • Hepatitis C virus

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors. / Shuhart, M. C.; Myerson, D.; Spurgeon, C. L.; Bevan, C. A.; Sayers, M. H.; McDonald, G. B.

In: Bone Marrow Transplantation, Vol. 17, No. 4, 04.1996, p. 601-606.

Research output: Contribution to journalArticle

Shuhart, M. C. ; Myerson, D. ; Spurgeon, C. L. ; Bevan, C. A. ; Sayers, M. H. ; McDonald, G. B. / Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors. In: Bone Marrow Transplantation. 1996 ; Vol. 17, No. 4. pp. 601-606.
@article{991337e7a237478ebfc7040ac58fa7db,
title = "Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors",
abstract = "In March 1992, 12 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center received blood components from donors who were anti-HCV-nonreactive by first generation ELISA but whose serum later tested anti-HCV-reactive to a second generation ELISA. All these blood components were further tested for anti-HCV using a second-generation RIBA and for HCV RNA by polymerase chain reaction. Recipient sera were tested for HCV RNA prior to and following blood component infusion. Blood components from four donors were positive for HCV RNA. All recipients of HCV RNA-positive blood components became viremic on the first day tested post-infusion. In addition, two recipients of HCV RNA-negative blood components tested HCV RNA-positive both pre- and post-infusion. Viremia persisted up to the time of death or day 100 in five of the six patients who were HCV RNA-positive post-transplant. No HCV RNA-positive recipient developed symptomatic acute hepatitis, and only two had aminotransferase elevations consistent with chronic hepatitis. We conclude that HCV RNA-positivity in blood components accurately predicts transmission of virus. Infection with HCV did not adversely affect short-term patient outcome following bone marrow transplantation.",
keywords = "Blood transfusion, Bone marrow transplantation, Hepatitis C virus",
author = "Shuhart, {M. C.} and D. Myerson and Spurgeon, {C. L.} and Bevan, {C. A.} and Sayers, {M. H.} and McDonald, {G. B.}",
year = "1996",
month = "4",
language = "English (US)",
volume = "17",
pages = "601--606",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors

AU - Shuhart, M. C.

AU - Myerson, D.

AU - Spurgeon, C. L.

AU - Bevan, C. A.

AU - Sayers, M. H.

AU - McDonald, G. B.

PY - 1996/4

Y1 - 1996/4

N2 - In March 1992, 12 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center received blood components from donors who were anti-HCV-nonreactive by first generation ELISA but whose serum later tested anti-HCV-reactive to a second generation ELISA. All these blood components were further tested for anti-HCV using a second-generation RIBA and for HCV RNA by polymerase chain reaction. Recipient sera were tested for HCV RNA prior to and following blood component infusion. Blood components from four donors were positive for HCV RNA. All recipients of HCV RNA-positive blood components became viremic on the first day tested post-infusion. In addition, two recipients of HCV RNA-negative blood components tested HCV RNA-positive both pre- and post-infusion. Viremia persisted up to the time of death or day 100 in five of the six patients who were HCV RNA-positive post-transplant. No HCV RNA-positive recipient developed symptomatic acute hepatitis, and only two had aminotransferase elevations consistent with chronic hepatitis. We conclude that HCV RNA-positivity in blood components accurately predicts transmission of virus. Infection with HCV did not adversely affect short-term patient outcome following bone marrow transplantation.

AB - In March 1992, 12 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center received blood components from donors who were anti-HCV-nonreactive by first generation ELISA but whose serum later tested anti-HCV-reactive to a second generation ELISA. All these blood components were further tested for anti-HCV using a second-generation RIBA and for HCV RNA by polymerase chain reaction. Recipient sera were tested for HCV RNA prior to and following blood component infusion. Blood components from four donors were positive for HCV RNA. All recipients of HCV RNA-positive blood components became viremic on the first day tested post-infusion. In addition, two recipients of HCV RNA-negative blood components tested HCV RNA-positive both pre- and post-infusion. Viremia persisted up to the time of death or day 100 in five of the six patients who were HCV RNA-positive post-transplant. No HCV RNA-positive recipient developed symptomatic acute hepatitis, and only two had aminotransferase elevations consistent with chronic hepatitis. We conclude that HCV RNA-positivity in blood components accurately predicts transmission of virus. Infection with HCV did not adversely affect short-term patient outcome following bone marrow transplantation.

KW - Blood transfusion

KW - Bone marrow transplantation

KW - Hepatitis C virus

UR - http://www.scopus.com/inward/record.url?scp=0029865690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029865690&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 601

EP - 606

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -